+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Next Generation Sequencing Market Research Report by Type, Technology, Application, End User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • ID: 4968842
  • Report
  • April 2022
  • Region: Global
  • 180 Pages
  • 360iResearch™
UP TO OFF until Dec 31st 2022
The Global Next Generation Sequencing Market size was estimated at USD 12.09 billion in 2021, USD 14.85 billion in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 22.98% to reach USD 41.84 billion by 2027.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Next Generation Sequencing to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Type, the market was studied across NGS Data Analysis, Storage, & Management, NGS Platforms, Consumables, & Services, and Pre-sequencing.
  • Based on Technology, the market was studied across Targeted Sequencing & Re-sequencing, Whole Exome Sequencing, and Whole Genome Sequencing.
  • Based on Application, the market was studied across Agriculture, Biomarker Discovery, Diagnostics, Drug Discovery, and Precision Medicine.
  • Based on End User, the market was studied across Academic & Research Institutes, Infectious Diseases, and Pharmaceutical & Biotechnology Companies.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.

This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Next Generation Sequencing market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Next Generation Sequencing Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Next Generation Sequencing Market, including 10x Genomics, Agilent Technologies, Inc., Beijing Genomics Co. Ltd., Beijing Genomics Institute (BGI), Bio-Rad Laboratories, Inc., BioMerieux S.A., Charles River Laboratories, Inc., DNASTAR, Inc, Eurofins Scientific, F. Hoffmann-La Roche AG, Gatc Biotech AG, Genomatix GmbH, Genome Life Sciences, GenScript Biotech Corporation, Illumina, Inc., Macrogen, Inc., NanoString Technologies, Inc., Oxford Nanopore Technologies, Ltd., Pacific Biosciences of California, Inc., Partek, Inc., Perkin Elmer, Inc., PierianDx, Inc., Qiagen N.V., Saphetor SA, Takara Bio Inc., Thermo Fisher Scientific, Inc., Xcelris Genomics, Ltd, and Zymo Research.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Next Generation Sequencing Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Next Generation Sequencing Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Next Generation Sequencing Market?
4. What is the competitive strategic window for opportunities in the Global Next Generation Sequencing Market?
5. What are the technology trends and regulatory frameworks in the Global Next Generation Sequencing Market?
6. What is the market share of the leading vendors in the Global Next Generation Sequencing Market?
7. What modes and strategic moves are considered suitable for entering the Global Next Generation Sequencing Market?
Frequently Asked Questions about the Global Next Generation Sequencing Market

What is the estimated value of the Global Next Generation Sequencing Market?

The Global Next Generation Sequencing Market was estimated to be valued at $12.1 Billion in 2021.

What is the growth rate of the Global Next Generation Sequencing Market?

The growth rate of the Global Next Generation Sequencing Market is 22.9%, with an estimated value of $41.8 Billion by 2027.

What is the forecasted size of the Global Next Generation Sequencing Market?

The Global Next Generation Sequencing Market is estimated to be worth $41.8 Billion by 2027.

Who are the key companies in the Global Next Generation Sequencing Market?

Key companies in the Global Next Generation Sequencing Market include 10x Genomics, Agilent Technologies, Inc., Beijing Genomics Co. Ltd., Beijing Genomics Institute (BGI), Bio, Rad Laboratories, Inc., BioMerieux S.A., Charles River Laboratories, Inc. and Eurofins Scientific.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing need of inexpensive sequencing devices in routine medical checkups and clinical settings
5.1.1.2. Need for operator independent accuracy and minimal hands-on time
5.1.1.3. Transformation of clinical microbiology and public health laboratories
5.1.1.4. Need to develop the single workflow for cancer research, human identification applications, inherited disease research, and infectious disease research
5.1.2. Restraints
5.1.2.1. Huge data processing and reimbursement uncertainty in clinical settings
5.1.2.2. Limited supplementary standards and guidance for NGS applications
5.1.2.3. Lack of skilled professionals
5.1.3. Opportunities
5.1.3.1. Potential significance of NGS analysis in identifying cancer mutations
5.1.3.2. Investigative NGS use to enable single-cell genomics
5.1.3.3. Service providers offering the cloud-based alternative to in-house platforms
5.1.3.4. High degree of collaboration and M&A activity in market space
5.1.4. Challenges
5.1.4.1. High library prep costs
5.1.4.2. Security and privacy of concerns for NGS Data
5.1.4.3. Data analysis and bioinformatics challenges
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of 2022 Russia Ukraine Conflict
6. Next Generation Sequencing Market, by Type
6.1. Introduction
6.2. NGS Data Analysis, Storage, & Management
6.3. NGS Platforms, Consumables, & Services
6.4. Pre-sequencing
7. Next Generation Sequencing Market, by Technology
7.1. Introduction
7.2. Targeted Sequencing & Re-sequencing
7.3. Whole Exome Sequencing
7.4. Whole Genome Sequencing
8. Next Generation Sequencing Market, by Application
8.1. Introduction
8.2. Agriculture
8.3. Biomarker Discovery
8.4. Diagnostics
8.5. Drug Discovery
8.6. Precision Medicine
9. Next Generation Sequencing Market, by End User
9.1. Introduction
9.2. Academic & Research Institutes
9.3. Infectious Diseases
9.4. Pharmaceutical & Biotechnology Companies
10. Americas Next Generation Sequencing Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Next Generation Sequencing Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
12. Europe, Middle East & Africa Next Generation Sequencing Market
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. 10x Genomics
14.2. Agilent Technologies, Inc.
14.3. Beijing Genomics Co. Ltd.
14.4. Beijing Genomics Institute (BGI)
14.5. Bio-Rad Laboratories, Inc.
14.6. BioMerieux S.A.
14.7. Charles River Laboratories, Inc.
14.8. DNASTAR, Inc
14.9. Eurofins Scientific
14.10. F. Hoffmann-La Roche AG
14.11. Gatc Biotech AG
14.12. Genomatix GmbH
14.13. Genome Life Sciences
14.14. GenScript Biotech Corporation
14.15. Illumina, Inc.
14.16. Macrogen, Inc.
14.17. NanoString Technologies, Inc.
14.18. Oxford Nanopore Technologies, Ltd.
14.19. Pacific Biosciences of California, Inc.
14.20. Partek, Inc.
14.21. Perkin Elmer, Inc.
14.22. PierianDx, Inc.
14.23. Qiagen N.V.
14.24. Saphetor SA
14.25. Takara Bio Inc.
14.26. Thermo Fisher Scientific, Inc.
14.27. Xcelris Genomics, Ltd
14.28. Zymo Research
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL NEXT GENERATION SEQUENCING MARKET: DYNAMICS
FIGURE 2. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY TYPE, 2021 VS 2027 (%)
FIGURE 3. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY TYPE, 2021 VS 2027 (USD BILLION)
FIGURE 4. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY TYPE, 2027
FIGURE 5. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY NGS DATA ANALYSIS, STORAGE, & MANAGEMENT, 2019-2027 (USD BILLION)
FIGURE 6. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY NGS DATA ANALYSIS, STORAGE, & MANAGEMENT, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 7. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY NGS PLATFORMS, CONSUMABLES, & SERVICES, 2019-2027 (USD BILLION)
FIGURE 8. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY NGS PLATFORMS, CONSUMABLES, & SERVICES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 9. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY PRE-SEQUENCING, 2019-2027 (USD BILLION)
FIGURE 10. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY PRE-SEQUENCING, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 11. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2021 VS 2027 (%)
FIGURE 12. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2021 VS 2027 (USD BILLION)
FIGURE 13. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2027
FIGURE 14. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY TARGETED SEQUENCING & RE-SEQUENCING, 2019-2027 (USD BILLION)
FIGURE 15. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY TARGETED SEQUENCING & RE-SEQUENCING, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 16. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY WHOLE EXOME SEQUENCING, 2019-2027 (USD BILLION)
FIGURE 17. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY WHOLE EXOME SEQUENCING, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 18. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY WHOLE GENOME SEQUENCING, 2019-2027 (USD BILLION)
FIGURE 19. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 20. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2021 VS 2027 (%)
FIGURE 21. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2021 VS 2027 (USD BILLION)
FIGURE 22. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2027
FIGURE 23. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY AGRICULTURE, 2019-2027 (USD BILLION)
FIGURE 24. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY AGRICULTURE, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 25. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY BIOMARKER DISCOVERY, 2019-2027 (USD BILLION)
FIGURE 26. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY BIOMARKER DISCOVERY, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 27. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY DIAGNOSTICS, 2019-2027 (USD BILLION)
FIGURE 28. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 29. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY DRUG DISCOVERY, 2019-2027 (USD BILLION)
FIGURE 30. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 31. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY PRECISION MEDICINE, 2019-2027 (USD BILLION)
FIGURE 32. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY PRECISION MEDICINE, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 33. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2021 VS 2027 (%)
FIGURE 34. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2021 VS 2027 (USD BILLION)
FIGURE 35. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2027
FIGURE 36. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2019-2027 (USD BILLION)
FIGURE 37. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 38. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY INFECTIOUS DISEASES, 2019-2027 (USD BILLION)
FIGURE 39. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 40. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2019-2027 (USD BILLION)
FIGURE 41. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 42. AMERICAS NEXT GENERATION SEQUENCING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 43. ARGENTINA NEXT GENERATION SEQUENCING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 44. BRAZIL NEXT GENERATION SEQUENCING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 45. CANADA NEXT GENERATION SEQUENCING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 46. MEXICO NEXT GENERATION SEQUENCING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 47. UNITED STATES NEXT GENERATION SEQUENCING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 48. ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 49. AUSTRALIA NEXT GENERATION SEQUENCING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 50. CHINA NEXT GENERATION SEQUENCING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 51. INDIA NEXT GENERATION SEQUENCING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 52. INDONESIA NEXT GENERATION SEQUENCING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 53. JAPAN NEXT GENERATION SEQUENCING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 54. MALAYSIA NEXT GENERATION SEQUENCING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 55. PHILIPPINES NEXT GENERATION SEQUENCING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 56. SINGAPORE NEXT GENERATION SEQUENCING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 57. SOUTH KOREA NEXT GENERATION SEQUENCING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 58. TAIWAN NEXT GENERATION SEQUENCING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 59. THAILAND NEXT GENERATION SEQUENCING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 60. EUROPE, MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 61. FRANCE NEXT GENERATION SEQUENCING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 62. GERMANY NEXT GENERATION SEQUENCING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 63. ITALY NEXT GENERATION SEQUENCING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 64. NETHERLANDS NEXT GENERATION SEQUENCING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 65. QATAR NEXT GENERATION SEQUENCING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 66. RUSSIA NEXT GENERATION SEQUENCING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 67. SAUDI ARABIA NEXT GENERATION SEQUENCING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 68. SOUTH AFRICA NEXT GENERATION SEQUENCING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 69. SPAIN NEXT GENERATION SEQUENCING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 70. UNITED ARAB EMIRATES NEXT GENERATION SEQUENCING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 71. UNITED KINGDOM NEXT GENERATION SEQUENCING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 72. GLOBAL NEXT GENERATION SEQUENCING MARKET: FPNV POSITIONING MATRIX
FIGURE 73. GLOBAL NEXT GENERATION SEQUENCING MARKET: SHARE, BY KEY PLAYER, 2021
FIGURE 74. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL NEXT GENERATION SEQUENCING MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL NEXT GENERATION SEQUENCING MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY TYPE, 2019-2027 (USD BILLION)
TABLE 4. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY NGS DATA ANALYSIS, STORAGE, & MANAGEMENT, BY REGION, 2019-2027 (USD BILLION)
TABLE 5. AMERICAS NEXT GENERATION SEQUENCING MARKET SIZE, BY NGS DATA ANALYSIS, STORAGE, & MANAGEMENT, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 6. UNITED STATES NEXT GENERATION SEQUENCING MARKET SIZE, BY NGS DATA ANALYSIS, STORAGE, & MANAGEMENT, BY STATE, 2019-2027 (USD BILLION)
TABLE 7. ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET SIZE, BY NGS DATA ANALYSIS, STORAGE, & MANAGEMENT, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 8. EUROPE, MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING MARKET SIZE, BY NGS DATA ANALYSIS, STORAGE, & MANAGEMENT, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 9. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY NGS PLATFORMS, CONSUMABLES, & SERVICES, BY REGION, 2019-2027 (USD BILLION)
TABLE 10. AMERICAS NEXT GENERATION SEQUENCING MARKET SIZE, BY NGS PLATFORMS, CONSUMABLES, & SERVICES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 11. UNITED STATES NEXT GENERATION SEQUENCING MARKET SIZE, BY NGS PLATFORMS, CONSUMABLES, & SERVICES, BY STATE, 2019-2027 (USD BILLION)
TABLE 12. ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET SIZE, BY NGS PLATFORMS, CONSUMABLES, & SERVICES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 13. EUROPE, MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING MARKET SIZE, BY NGS PLATFORMS, CONSUMABLES, & SERVICES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 14. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY PRE-SEQUENCING, BY REGION, 2019-2027 (USD BILLION)
TABLE 15. AMERICAS NEXT GENERATION SEQUENCING MARKET SIZE, BY PRE-SEQUENCING, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 16. UNITED STATES NEXT GENERATION SEQUENCING MARKET SIZE, BY PRE-SEQUENCING, BY STATE, 2019-2027 (USD BILLION)
TABLE 17. ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET SIZE, BY PRE-SEQUENCING, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 18. EUROPE, MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING MARKET SIZE, BY PRE-SEQUENCING, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 19. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD BILLION)
TABLE 20. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY TARGETED SEQUENCING & RE-SEQUENCING, BY REGION, 2019-2027 (USD BILLION)
TABLE 21. AMERICAS NEXT GENERATION SEQUENCING MARKET SIZE, BY TARGETED SEQUENCING & RE-SEQUENCING, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 22. UNITED STATES NEXT GENERATION SEQUENCING MARKET SIZE, BY TARGETED SEQUENCING & RE-SEQUENCING, BY STATE, 2019-2027 (USD BILLION)
TABLE 23. ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET SIZE, BY TARGETED SEQUENCING & RE-SEQUENCING, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 24. EUROPE, MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING MARKET SIZE, BY TARGETED SEQUENCING & RE-SEQUENCING, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 25. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY WHOLE EXOME SEQUENCING, BY REGION, 2019-2027 (USD BILLION)
TABLE 26. AMERICAS NEXT GENERATION SEQUENCING MARKET SIZE, BY WHOLE EXOME SEQUENCING, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 27. UNITED STATES NEXT GENERATION SEQUENCING MARKET SIZE, BY WHOLE EXOME SEQUENCING, BY STATE, 2019-2027 (USD BILLION)
TABLE 28. ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET SIZE, BY WHOLE EXOME SEQUENCING, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 29. EUROPE, MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING MARKET SIZE, BY WHOLE EXOME SEQUENCING, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 30. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2019-2027 (USD BILLION)
TABLE 31. AMERICAS NEXT GENERATION SEQUENCING MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 32. UNITED STATES NEXT GENERATION SEQUENCING MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY STATE, 2019-2027 (USD BILLION)
TABLE 33. ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 34. EUROPE, MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 35. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 36. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY AGRICULTURE, BY REGION, 2019-2027 (USD BILLION)
TABLE 37. AMERICAS NEXT GENERATION SEQUENCING MARKET SIZE, BY AGRICULTURE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 38. UNITED STATES NEXT GENERATION SEQUENCING MARKET SIZE, BY AGRICULTURE, BY STATE, 2019-2027 (USD BILLION)
TABLE 39. ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET SIZE, BY AGRICULTURE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 40. EUROPE, MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING MARKET SIZE, BY AGRICULTURE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 41. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY BIOMARKER DISCOVERY, BY REGION, 2019-2027 (USD BILLION)
TABLE 42. AMERICAS NEXT GENERATION SEQUENCING MARKET SIZE, BY BIOMARKER DISCOVERY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 43. UNITED STATES NEXT GENERATION SEQUENCING MARKET SIZE, BY BIOMARKER DISCOVERY, BY STATE, 2019-2027 (USD BILLION)
TABLE 44. ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET SIZE, BY BIOMARKER DISCOVERY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 45. EUROPE, MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING MARKET SIZE, BY BIOMARKER DISCOVERY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 46. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2019-2027 (USD BILLION)
TABLE 47. AMERICAS NEXT GENERATION SEQUENCING MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 48. UNITED STATES NEXT GENERATION SEQUENCING MARKET SIZE, BY DIAGNOSTICS, BY STATE, 2019-2027 (USD BILLION)
TABLE 49. ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 50. EUROPE, MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 51. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2019-2027 (USD BILLION)
TABLE 52. AMERICAS NEXT GENERATION SEQUENCING MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 53. UNITED STATES NEXT GENERATION SEQUENCING MARKET SIZE, BY DRUG DISCOVERY, BY STATE, 2019-2027 (USD BILLION)
TABLE 54. ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 55. EUROPE, MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 56. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY PRECISION MEDICINE, BY REGION, 2019-2027 (USD BILLION)
TABLE 57. AMERICAS NEXT GENERATION SEQUENCING MARKET SIZE, BY PRECISION MEDICINE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 58. UNITED STATES NEXT GENERATION SEQUENCING MARKET SIZE, BY PRECISION MEDICINE, BY STATE, 2019-2027 (USD BILLION)
TABLE 59. ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET SIZE, BY PRECISION MEDICINE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 60. EUROPE, MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING MARKET SIZE, BY PRECISION MEDICINE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 61. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
TABLE 62. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2019-2027 (USD BILLION)
TABLE 63. AMERICAS NEXT GENERATION SEQUENCING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 64. UNITED STATES NEXT GENERATION SEQUENCING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY STATE, 2019-2027 (USD BILLION)
TABLE 65. ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 66. EUROPE, MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 67. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2019-2027 (USD BILLION)
TABLE 68. AMERICAS NEXT GENERATION SEQUENCING MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 69. UNITED STATES NEXT GENERATION SEQUENCING MARKET SIZE, BY INFECTIOUS DISEASES, BY STATE, 2019-2027 (USD BILLION)
TABLE 70. ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 71. EUROPE, MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 72. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2019-2027 (USD BILLION)
TABLE 73. AMERICAS NEXT GENERATION SEQUENCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 74. UNITED STATES NEXT GENERATION SEQUENCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY STATE, 2019-2027 (USD BILLION)
TABLE 75. ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 76. EUROPE, MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 77. AMERICAS NEXT GENERATION SEQUENCING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 78. ARGENTINA NEXT GENERATION SEQUENCING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 79. BRAZIL NEXT GENERATION SEQUENCING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 80. CANADA NEXT GENERATION SEQUENCING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 81. MEXICO NEXT GENERATION SEQUENCING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 82. UNITED STATES NEXT GENERATION SEQUENCING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 83. ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 84. AUSTRALIA NEXT GENERATION SEQUENCING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 85. CHINA NEXT GENERATION SEQUENCING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 86. INDIA NEXT GENERATION SEQUENCING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 87. INDONESIA NEXT GENERATION SEQUENCING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 88. JAPAN NEXT GENERATION SEQUENCING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 89. MALAYSIA NEXT GENERATION SEQUENCING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 90. PHILIPPINES NEXT GENERATION SEQUENCING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 91. SINGAPORE NEXT GENERATION SEQUENCING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 92. SOUTH KOREA NEXT GENERATION SEQUENCING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 93. TAIWAN NEXT GENERATION SEQUENCING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 94. THAILAND NEXT GENERATION SEQUENCING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 96. FRANCE NEXT GENERATION SEQUENCING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 97. GERMANY NEXT GENERATION SEQUENCING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 98. ITALY NEXT GENERATION SEQUENCING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 99. NETHERLANDS NEXT GENERATION SEQUENCING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 100. QATAR NEXT GENERATION SEQUENCING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 101. RUSSIA NEXT GENERATION SEQUENCING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 102. SAUDI ARABIA NEXT GENERATION SEQUENCING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 103. SOUTH AFRICA NEXT GENERATION SEQUENCING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 104. SPAIN NEXT GENERATION SEQUENCING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 105. UNITED ARAB EMIRATES NEXT GENERATION SEQUENCING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 106. UNITED KINGDOM NEXT GENERATION SEQUENCING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 107. GLOBAL NEXT GENERATION SEQUENCING MARKET: SCORES
TABLE 108. GLOBAL NEXT GENERATION SEQUENCING MARKET: BUSINESS STRATEGY
TABLE 109. GLOBAL NEXT GENERATION SEQUENCING MARKET: PRODUCT SATISFACTION
TABLE 110. GLOBAL NEXT GENERATION SEQUENCING MARKET: RANKING
TABLE 111. GLOBAL NEXT GENERATION SEQUENCING MARKET: SHARE, BY KEY PLAYER, 2021
TABLE 112. GLOBAL NEXT GENERATION SEQUENCING MARKET: MERGER & ACQUISITION
TABLE 113. GLOBAL NEXT GENERATION SEQUENCING MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 114. GLOBAL NEXT GENERATION SEQUENCING MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 115. GLOBAL NEXT GENERATION SEQUENCING MARKET: INVESTMENT & FUNDING
TABLE 116. GLOBAL NEXT GENERATION SEQUENCING MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 117. GLOBAL NEXT GENERATION SEQUENCING MARKET: LICENSE & PRICING

Companies Mentioned

  • 10x Genomics
  • Agilent Technologies, Inc.
  • Beijing Genomics Co. Ltd.
  • Beijing Genomics Institute (BGI)
  • Bio-Rad Laboratories, Inc.
  • BioMerieux S.A.
  • Charles River Laboratories, Inc.
  • DNASTAR, Inc
  • Eurofins Scientific
  • F. Hoffmann-La Roche AG
  • Gatc Biotech AG
  • Genomatix GmbH
  • Genome Life Sciences
  • GenScript Biotech Corporation
  • Illumina, Inc.
  • Macrogen, Inc.
  • NanoString Technologies, Inc.
  • Oxford Nanopore Technologies, Ltd.
  • Pacific Biosciences of California, Inc.
  • Partek, Inc.
  • Perkin Elmer, Inc.
  • PierianDx, Inc.
  • Qiagen N.V.
  • Saphetor SA
  • Takara Bio Inc.
  • Thermo Fisher Scientific, Inc.
  • Xcelris Genomics, Ltd
  • Zymo Research

Methodology

Loading
LOADING...